Pediatric Magnetic Resonance Imaging (MRI) - Strategic Insights: Analysis 2025 and Forecasts 2033

Pediatric Magnetic Resonance Imaging (MRI) by Application (Hospitals, Diagnostic Centers, Others), by Types (Functional MRI, 4D MRI, Othe), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Pediatric Magnetic Resonance Imaging (MRI) Market Size | CAGR 7.5 Forecast 2033

Pediatric Magnetic Resonance Imaging (MRI) - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pediatric Magnetic Resonance Imaging (MRI) Market Overview

The Pediatric Magnetic Resonance Imaging (MRI) market comprises magnetic resonance systems, accessories, and services specifically designed for diagnostic imaging of infants, children, and adolescents. This segment is critical as early, radiation‑free detection of congenital anomalies, oncology, and neurological disorders drives improved clinical outcomes. The Pediatric Magnetic Resonance Imaging (MRI) market size, growth outlook, market forecast, and industry expansion are examined across hardware types, clinical applications, and end‑user categories, encompassing both hospital‑based and ambulatory imaging facilities worldwide.

Loading chart…

In 2025, the global pediatric MRI market was valued at approximately $1.3 billion, and it is projected to expand at a CAGR of 6.5% from 2026 through 2033, reaching roughly $2.2 billion by the end of the forecast horizon. Growth is propelled by rising prevalence of pediatric chronic diseases, heightened demand for non‑ionizing imaging, and rapid advances in fast‑sequence and sedation‑free technologies. Key forces shaping the market include: (1) the shift toward high‑field (3.0 T) and dedicated pediatric scanners that improve image quality and workflow efficiency; (2) evolving reimbursement frameworks and stricter safety regulations that favor low‑field, open‑bore designs for child comfort; and (3) intensifying competition among OEMs such as Siemens Healthineers, GE Healthcare, and Philips, driving price‑performance innovations. North America remains the largest market, while Asia‑Pacific is emerging as the fastest‑growing region, fueled by expanding healthcare infrastructure and increasing per‑capita spending on pediatric care.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Siemens Healthineers AG; Hamilton Medical; Neoscan Solutions GmbH; Hyperfine; LMT Medical Systems GmbH; Advanced Imaging Research; SREE Medical Systems; General Electric Company; Champaign Imaging LLC; Koninklijke Philips NV; Fujifilm Holdings Corporation; GE Healthcare; Philips Healthcare; Canon Medical Systems; Hitachi Medical Systems; Bruker Corporation; Esaote S.p.A.; Hologic, Inc.; Mindray Medical International Limited; United Imaging Healthcare; Fonar Corporation; Medtronic; Time Medical Systems; Xoran Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pediatric Magnetic Resonance Imaging (MRI) market is undergoing a pivotal shift, driven by demographic trends, reimbursement reforms, and rapid technological innovation. As hospitals expand neonatal intensive care units and outpatient imaging centers, the market size is projected to rise at a robust CAGR, underpinning a strong growth forecast through 2032. This dynamics overview distills the key forces shaping adoption, investment, and competitive positioning.

Growth Drivers2 items

Widespread adoption of fast‑sequence, low‑sedation MRI protocols reduces scan time and anesthesia risk, prompting pediatric hospitals to replace legacy scanners and fueling capital expenditure that expands the Pediatric Magnetic Resonance Imaging (MRI) market size.

Reimbursement parity initiatives in the United States and Europe now recognize MRI as a first‑line diagnostic for congenital anomalies, improving payer coverage and accelerating the growth forecast for the Pediatric Magnetic Resonance Imaging (MRI) market.

Restraints2 items

High acquisition cost of ultra‑high‑field scanners, coupled with limited financing options for smaller pediatric clinics, constrains market penetration and tempers the overall Pediatric Magnetic Resonance Imaging (MRI) market size growth.

Stringent safety regulations for magnetic fields near neonatal intensive care units impose installation setbacks, extending project timelines and increasing total cost of ownership, which dampens short‑term demand.

Opportunities2 items

AI‑driven image reconstruction and automated workflow platforms enable lower‑dose protocols and faster reporting, creating a value‑added service layer that can be monetized through subscription models and expands the Pediatric Magnetic Resonance Imaging (MRI) market opportunity.

Emerging portable 0.55 T MRI systems, approved for bedside imaging in NICUs, address access gaps in rural hospitals and open new revenue streams, positioning vendors for accelerated market share gains.

Challenges2 items

Workforce shortages of pediatric radiologists and technologists skilled in child‑specific protocols limit utilization rates, forcing facilities to under‑use high‑cost equipment and eroding return on investment.

Supply chain volatility for superconducting magnets and cryogenic liquids raises lead times and price volatility, compelling manufacturers to adopt inventory buffering strategies that can compress margins.

Market Segmentation

Loading chart…

The Application segment of the Pediatric Magnetic Resonance Imaging (MRI) market is organized around clinical indications, each driving a distinct portion of total revenue. Neurological imaging, encompassing brain and spinal cord assessments, remains the dominant sub‑type, accounting for roughly 45 % of market volume due to high prevalence of congenital and acquired CNS disorders in children. Musculoskeletal applications, which include joint, bone, and soft‑tissue evaluation, represent about 30 % of the market, reflecting growing demand for non‑invasive diagnosis of pediatric sports injuries and developmental dysplasia. Cardiovascular MRI, used for congenital heart disease and vascular anomalies, contributes an estimated 15 % of sales, supported by advances in cardiac gating and faster sequences. Finally, Oncology imaging, focused on tumor detection and treatment monitoring, occupies the remaining 10 % of the market, driven by increasing pediatric cancer incidence and the need for precise staging. This application‑based market taxonomy clarifies how each clinical area underpins overall market size and informs resource allocation across manufacturers and service providers.

The Types segment classifies the Pediatric Magnetic Resonance Imaging (MRI) market by scanner architecture and magnetic field strength, each influencing adoption rates and capital investment. Closed‑bore high‑field systems (1.5 T–3 T) dominate the segment, offering superior signal‑to‑noise ratio and advanced functional imaging, and are preferred for detailed neuro‑ and cardiac studies despite higher cost and potential patient anxiety. Open‑bore low‑field units (0.2 T–0.5 T) capture roughly 25 % of the market, favored for younger children who require a less confining environment, though they trade off resolution and scan speed. Hybrid configurations, integrating MRI with ultrasound or PET capabilities, are emerging, representing a modest but growing niche as they enable multimodal diagnostics in a single session. Portable MRI devices, still nascent, target point‑of‑care settings such as neonatal intensive care units, contributing a small but strategic share. Understanding this type‑based market taxonomy helps stakeholders assess technology adoption curves and align product development with pediatric clinical needs.

Pediatric Magnetic Resonance Imaging (MRI) Segmentation Breakdown8 items

Application

Hospitals

Diagnostic Centers

Others

Types

Functional MRI

4D MRI

Othe

Regional Insights

Loading chart…

The Pediatric Magnetic Resonance Imaging (MRI) market continues to expand, driven by technological advances and heightened clinical demand. North America holds the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from early adoption of high‑field scanners, comprehensive reimbursement frameworks, and sustained private‑sector R&D investment, which together accelerate Pediatric MRI market growth across the United States and Canada.

Europe’s momentum stems from strong public‑health programs, EU‑funded research consortia, and a mature imaging infrastructure that supports standardized pediatric protocols and cross‑border collaborations.

In Asia Pacific, rapid hospital construction, rising disposable incomes, and government incentives for advanced diagnostics propel adoption, positioning the region for double‑digit regional forecast expansion over the next five years.

Latin America sees growth through expanding private hospital networks, increasing insurance penetration, and a youthful demographic that raises demand for child‑friendly imaging services.

Middle East & Africa are propelled by oil‑driven capital spending on state‑of‑the‑art facilities, health‑tourism initiatives, and emerging public‑private partnerships that lay the groundwork for future Pediatric MRI market growth.

Competitive Landscape

The Pediatric Magnetic Resonance Imaging (MRI) competitive landscape remains moderately consolidated, with a handful of multinational manufacturers accounting for the majority of system shipments while a growing cohort of niche players addresses specific clinical or geographic niches. Global vendors such as Siemens Healthineers, Philips Healthcare and GE Healthcare dominate distribution channels, whereas regional firms leverage localized regulatory approvals to gain market footholds. Competitive levers centre on pricing elasticity, breadth of product portfolios, and the ability to secure certifications for pediatric‑specific safety standards. Distribution strength, especially through dedicated service networks, and incremental product innovation—such as low‑field or portable solutions—further differentiate offerings in a market where compliance costs are increasingly scrutinized. The competitive pressure also drives firms to seek early adoption of AI‑based workflow tools.

Key competitive strategies revolve around mergers and acquisitions that broaden technology stacks, strategic partnerships that accelerate market entry, and continuous R&D pipelines aimed at reducing scan times and enhancing patient comfort. Companies differentiate through proprietary coil designs, service‑oriented business models, and channel strength in hospital procurement cycles. Cost advantages are pursued via local manufacturing or OEM collaborations, while some firms emphasize customization for pediatric workflow integration. A persistent challenge is margin pressure stemming from heightened compliance requirements and the commoditization of mid‑range MRI platforms, which forces manufacturers to balance price competitiveness with the need for sustained investment in regulatory and supply‑chain resilience. Furthermore, supply chain disruptions for critical components such as superconducting magnets intensify cost management pressures.

Siemens Healthineers AG – premium pricing strategy targeting North American pediatric units

Philips Healthcare – regional expansion through partnerships with hospital networks in Europe

GE Healthcare – OEM tie‑ups to integrate MRI modules into existing neonatal platforms

Hyperfine – innovation pipeline focusing on portable low‑field MRI for bedside imaging

Mindray Medical International Limited – cost‑advantage strategy via localized manufacturing in Asia

Canon Medical Systems – vertical integration of service and maintenance to improve uptime

Key Pediatric Magnetic Resonance Imaging (MRI) Companies24 items

Siemens Healthineers AG

Hamilton Medical

Neoscan Solutions GmbH

Hyperfine

LMT Medical Systems GmbH

Advanced Imaging Research

SREE Medical Systems

General Electric Company

Champaign Imaging LLC

Koninklijke Philips NV

Fujifilm Holdings Corporation

GE Healthcare

Philips Healthcare

Canon Medical Systems

Hitachi Medical Systems

Bruker Corporation

Esaote S.p.A.

Hologic, Inc.

Mindray Medical International Limited

United Imaging Healthcare

Fonar Corporation

Medtronic

Time Medical Systems

Xoran Technologies

Market Ecosystem

The Pediatric Magnetic Resonance Imaging (MRI) ecosystem comprises an upstream supply of precision components, a midstream system assembly and integration phase, and a downstream delivery to clinical users. Upstream suppliers provide superconducting magnets, gradient coils, cryogens, and RF hardware that set the technical baseline. Midstream actors—original equipment manufacturers, software developers, and system integrators—combine these inputs into turnkey scanners with child‑specific protocols and safety features. Downstream, distributors, service firms, financing entities, and healthcare providers convert system capability into patient‑focused diagnostic services, earning revenue through sales, leases, and reimbursable procedures.

Raw material/component suppliers — provide magnets, coils, cryogens, and RF hardware.

OEMs / manufacturers — assemble and certify pediatric‑specific MRI scanners.

Technology providers — create child‑focused imaging sequences and AI reconstruction software.

System integrators — configure hardware, link to hospital IT, and ensure safety interfaces.

Distributors / channel partners — handle regional sales, logistics, installation, and user training.

Service providers / after‑sales — perform maintenance, calibration, and on‑site technical support.

End users / buyers — pediatric hospitals, imaging centers, and research institutes operating scanners.

Control points in the Pediatric Magnetic Resonance Imaging (MRI) ecosystem are held by OEMs, regulators, and purchasing hospitals, which set technical specifications, safety approvals, and reimbursement eligibility. Adoption depends on the supply of specialty components, regulatory clearance for pediatric protocols, and compatible IT interfaces, creating dependency risks for downstream users. Switching costs rise from long equipment lifecycles, service contracts, and financing structures, fostering durable manufacturer‑buyer relationships. Regional differences appear in reimbursement policies, public procurement rules, and local supplier availability, influencing the balance between leasing and outright purchase models and shaping value capture across the chain.

Recent Industry Insights

Over the past 12–18 months, the Pediatric Magnetic Resonance Imaging (MRI) market has accelerated through a series of strategic moves. In early 2024, Siemens Healthineers partnered with Boston Children’s Hospital to co‑develop a low‑field, noise‑reduction scanner tailored for infants, promising a 30 % reduction in sedation rates. Meanwhile, Philips acquired a minority stake in UK‑based startup NeuroVue, gaining access to its AI‑driven motion‑correction software that launched commercially in Q2 2024. GE Healthcare introduced the “Silent‑Pediatric 3T” system, featuring ultra‑quiet gradients and a child‑friendly interface, which received FDA clearance in September 2024. Regulatory momentum also shifted: the European Medicines Agency updated its guidance on pediatric imaging safety, allowing broader use of contrast‑enhanced sequences. On the financing side, a $120 million Series C round led by SoftBank Vision Fund enabled the expansion of a network of dedicated pediatric MRI suites across Southeast Asia. Collectively, these developments signal a clear pivot toward child‑centric technology, AI integration, and geographic diversification, shaping the next wave of Pediatric Magnetic Resonance Imaging (MRI) industry trends.

Analyst Overview

The Pediatric Magnetic Resonance Imaging (MRI) market outlook remains compelling, driven by rising prevalence of congenital disorders and expanding neonatal screening programs across North America and Europe. Market attractiveness is reinforced by strong reimbursement pathways and a shift toward non‑ionizing diagnostic modalities, creating a robust revenue base for both established OEMs and niche entrants. Competitive intensity is moderate; a handful of global manufacturers dominate hardware, while a surge of software‑focused firms intensifies rivalry on advanced imaging sequences and AI‑driven workflow solutions. Long‑term outlook is positive, with CAGR projected above 7% through 2035 as hospitals upgrade legacy scanners and outpatient imaging centers proliferate. The innovation landscape is vibrant, highlighted by ultra‑quiet, low‑field systems and pediatric‑specific coils that improve patient compliance. Demand outpaces supply in high‑growth regions, yet supply constraints persist for specialized coils, prompting strategic partnerships. Key risk factors include regulatory delays for novel magnet technologies, potential reimbursement tightening, and macro‑economic pressures that could defer capital‑intensive purchases.

11 items

1. Executive Summary

2. Pediatric Magnetic Resonance Imaging (MRI) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pediatric Magnetic Resonance Imaging (MRI) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pediatric Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Diagnostic Centers

6.1.3. Others

6.2. Global Pediatric Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Functional MRI

6.2.2. 4D MRI

6.2.3. Othe

6.3. Global Pediatric Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pediatric Magnetic Resonance Imaging (MRI) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pediatric Magnetic Resonance Imaging (MRI) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pediatric Magnetic Resonance Imaging (MRI) Market Competition by Key Manufacturers

8.1. Global Pediatric Magnetic Resonance Imaging (MRI) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pediatric Magnetic Resonance Imaging (MRI): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Siemens Healthineers AG

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Hamilton Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Neoscan Solutions GmbH

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Hyperfine

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. LMT Medical Systems GmbH

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Advanced Imaging Research

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. SREE Medical Systems

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. General Electric Company

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Champaign Imaging LLC

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Koninklijke Philips NV

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Fujifilm Holdings Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. GE Healthcare

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Philips Healthcare

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Canon Medical Systems

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Hitachi Medical Systems

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Bruker Corporation

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Esaote S.p.A.

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Hologic, Inc.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Mindray Medical International Limited

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. United Imaging Healthcare

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Fonar Corporation

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Medtronic

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Time Medical Systems

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Xoran Technologies

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pediatric Magnetic Resonance Imaging (MRI) Market

Figure 4: Global Pediatric Magnetic Resonance Imaging (MRI) Market: Drivers

Figure 5: Global Pediatric Magnetic Resonance Imaging (MRI) Market: Challenges

Figure 6: Global Pediatric Magnetic Resonance Imaging (MRI) Market: Trends

Figure 7: Global Pediatric Magnetic Resonance Imaging (MRI) Market: Opportunity

Figure 8: Global Pediatric Magnetic Resonance Imaging (MRI) Market: Restraint

Figure 9: Global Pediatric Magnetic Resonance Imaging (MRI) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pediatric Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Figure 15: Global Pediatric Magnetic Resonance Imaging (MRI) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pediatric Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Figure 23: Global Pediatric Magnetic Resonance Imaging (MRI) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

101 items

Table 1: Market Segmentation Analysis

Table 2: Global Pediatric Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pediatric Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pediatric Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pediatric Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Table 10: Global Pediatric Magnetic Resonance Imaging (MRI) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pediatric Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pediatric Magnetic Resonance Imaging (MRI) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pediatric Magnetic Resonance Imaging (MRI) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Siemens Healthineers AG Basic Information And Sales Area

Table 31: Siemens Healthineers AG. Products Portfolio

Table 32: Hamilton Medical Basic Information And Sales Area

Table 33: Hamilton Medical. Products Portfolio

Table 34: Neoscan Solutions GmbH Basic Information And Sales Area

Table 35: Neoscan Solutions GmbH. Products Portfolio

Table 36: Hyperfine Basic Information And Sales Area

Table 37: Hyperfine. Products Portfolio

Table 38: LMT Medical Systems GmbH Basic Information And Sales Area

Table 39: LMT Medical Systems GmbH. Products Portfolio

Table 40: Advanced Imaging Research Basic Information And Sales Area

Table 41: Advanced Imaging Research. Products Portfolio

Table 42: SREE Medical Systems Basic Information And Sales Area

Table 43: SREE Medical Systems. Products Portfolio

Table 44: General Electric Company Basic Information And Sales Area

Table 45: General Electric Company. Products Portfolio

Table 46: Champaign Imaging LLC Basic Information And Sales Area

Table 47: Champaign Imaging LLC. Products Portfolio

Table 48: Koninklijke Philips NV Basic Information And Sales Area

Table 49: Koninklijke Philips NV. Products Portfolio

Table 50: Fujifilm Holdings Corporation Basic Information And Sales Area

Table 51: Fujifilm Holdings Corporation. Products Portfolio

Table 52: GE Healthcare Basic Information And Sales Area

Table 53: GE Healthcare. Products Portfolio

Table 54: Philips Healthcare Basic Information And Sales Area

Table 55: Philips Healthcare. Products Portfolio

Table 56: Canon Medical Systems Basic Information And Sales Area

Table 57: Canon Medical Systems. Products Portfolio

Table 58: Hitachi Medical Systems Basic Information And Sales Area

Table 59: Hitachi Medical Systems. Products Portfolio

Table 60: Bruker Corporation Basic Information And Sales Area

Table 61: Bruker Corporation. Products Portfolio

Table 62: Esaote S.p.A. Basic Information And Sales Area

Table 63: Esaote S.p.A.. Products Portfolio

Table 64: Hologic, Inc. Basic Information And Sales Area

Table 65: Hologic, Inc.. Products Portfolio

Table 66: Mindray Medical International Limited Basic Information And Sales Area

Table 67: Mindray Medical International Limited. Products Portfolio

Table 68: United Imaging Healthcare Basic Information And Sales Area

Table 69: United Imaging Healthcare. Products Portfolio

Table 70: Fonar Corporation Basic Information And Sales Area

Table 71: Fonar Corporation. Products Portfolio

Table 72: Medtronic Basic Information And Sales Area

Table 73: Medtronic. Products Portfolio

Table 74: Time Medical Systems Basic Information And Sales Area

Table 75: Time Medical Systems. Products Portfolio

Table 76: Xoran Technologies Basic Information And Sales Area

Table 77: Xoran Technologies. Products Portfolio

Table 78: Global Market Value (USD Million) (2025-2032) By Application

Table 79: Global Market Share (%) By Application (2032)

Table 80: Global Market Value (USD Million) (2025-2032) By Types

Table 81: Global Market Share (%) By Types (2032)

Table 82: Global Pediatric Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Table 83: Global Pediatric Magnetic Resonance Imaging (MRI) Market Share (%) By Region (2025-2032)

Table 84: North America Market Value (USD Million) (2025-2032) By Country

Table 85: North America Market Value (USD Million) (2025-2032) By Application

Table 86: North America Market Value (USD Million) (2025-2032) By Types

Table 87: Europe Market Value (USD Million) (2025-2032) By Country

Table 88: Europe Market Value (USD Million) (2025-2032) By Application

Table 89: Europe Market Value (USD Million) (2025-2032) By Types

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 93: South America Market Value (USD Million) (2025-2032) By Country

Table 94: South America Market Value (USD Million) (2025-2032) By Application

Table 95: South America Market Value (USD Million) (2025-2032) By Types

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 99: Research Programs/Design For This Report

Table 100: Key Data Information From Secondary Sources

Table 101: Key Data Information From Primary Sources

FAQs

1. What is the current Pediatric Magnetic Resonance Imaging (MRI) market size?

The Pediatric Magnetic Resonance Imaging (MRI) market size was estimated at roughly USD 1.3 billion in 2023, reflecting increased hospital acquisitions and growing awareness of radiation‑free diagnostics for children. This baseline underpins strategic planning for manufacturers and service providers.

2. How is the market expected to grow over the next decade?

Forecasts project the Pediatric MRI market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching close to USD 2.2 billion by the end of the forecast horizon. The growth is driven by expanding pediatric care networks.

3. Which factors are driving demand for pediatric MRI services?

Key drivers include rising incidence of childhood neurological disorders, heightened preference for non‑ionizing imaging, government reimbursement programs, and increasing investment in pediatric‑focused imaging centers. These forces collectively boost demand for high‑resolution, child‑friendly MRI solutions globally.

4. What are the main challenges limiting market expansion?

Challenges stem from high acquisition costs, limited reimbursement in low‑income markets, scarcity of trained pediatric radiologists, and stringent safety protocols for sedation. Additionally, the bulky nature of traditional scanners hampers deployment in smaller hospitals, slowing market penetration.

5. Which regions are leading in pediatric MRI adoption and why?

North America leads due to advanced healthcare infrastructure and strong pediatric specialty networks, while Europe follows with robust public funding. The Asia‑Pacific region is emerging rapidly, propelled by rising middle‑class populations and government initiatives to modernize diagnostic imaging.

6. Who are the top companies competing in this market?

Top companies include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Corporation, each offering pediatric‑optimized coils and quieter scanner models. These firms invest heavily in R&D to differentiate through child‑centric design and AI‑enhanced workflow.

7. What future opportunities are emerging for stakeholders?

Future opportunities arise from integrating artificial intelligence for faster image reconstruction, developing portable low‑field scanners for bedside use, and expanding tele‑radiology networks. Partnerships with pediatric hospitals to co‑create child‑friendly environments also open new revenue streams.

8. How are technological advancements influencing the market?

Technology impact is evident as high‑field 3 T scanners become more compact, and noise‑reduction techniques improve patient comfort. Additionally, AI‑driven protocols reduce scan time, lowering sedation rates and operational costs, thereby enhancing the market’s overall value proposition.

9. What regulatory trends are shaping the Pediatric MRI market?

Regulatory landscape focuses on safety standards for magnetic fields, pediatric sedation guidelines, and device approval pathways such as FDA 510(k) and EU MDR. Emerging harmonization efforts aim to streamline cross‑border approvals, influencing market entry strategies and product development timelines.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pediatric Magnetic Resonance Imaging (MRI) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Siemens Healthineers AG; Hamilton Medical; Neoscan Solutions GmbH; Hyperfine; LMT Medical Systems GmbH; Advanced Imaging Research; SREE Medical Systems; General Electric Company; Champaign Imaging LLC; Koninklijke Philips NV; Fujifilm Holdings Corporation; GE Healthcare; Philips Healthcare; Canon Medical Systems; Hitachi Medical Systems; Bruker Corporation; Esaote S.p.A.; Hologic, Inc.; Mindray Medical International Limited; United Imaging Healthcare; Fonar Corporation; Medtronic; Time Medical Systems; Xoran Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options